dm+d

47898004

Articles

What injections can be given orally or via enteral feeding tubes?

6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…

What is the evidence for verapamil for prevention of cluster headache?

19 October 2020This updated Medicines Q&A evaluates the available evidence on the use of verapamil for the prevention of cluster headache Summary A cluster headache consists of…

Safety in Lactation: Drugs for hypertension

23 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Many of the drugs covered by…

How should ankle oedema caused by calcium channel blockers be treated?

1 June 2020Ankle oedema is a common, often troublesome adverse effect for patients who are receiving calcium channel blocker (CCB) therapy, and may affect compliance. It is…

What are the reported incidences of ankle oedema with different calcium channel blockers?

1 June 2020The potential to cause ankle oedema appears to exist for all calcium channel blocking agents, and is caused by increasing capillary pressure leading to leakage…
Search Articles

Medicine Compliance Aid Stability

Half Securon SRBGP Products Ltd

BGP Products Ltd
Half Securon SR
Tablets m/r 120mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
9 November 2015

Vertab SRChiesi Ltd

Chiesi Ltd
Vertab SR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
11 November 2015

UniverCephalon (UK) Ltd

Cephalon (UK) Ltd
Univer
Capsules m/r 120mg, 180mg, 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
9 November 2015

CordiloxDexcel Pharma Ltd

Dexcel Pharma Ltd
Cordilox
Tablets f/c 40mg, 80mg, 120mg, 160mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
9 November 2015

Verapress MRDexcel Pharma Ltd

Dexcel Pharma Ltd
Verapress MR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
9 November 2015

Securon SRBGP Products Ltd

BGP Products Ltd
Securon SR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
9 November 2015

Lactation Safety Information

Yes
-
Limited published evidence of safety
Doses up to 360mg daily produce small amounts in breast milk which would not be expected to cause adverse effects in the breastfed infant
3 August 2020